The pharmaceutical industry is broken. From the American hedge fund manager who hiked the price of an AIDS pill overnight to the children's cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system built to drive innovation and patient care has been distorted to boost profits.

Unless we take action we risk a dramatic decline in the pace of drug development and a future in which medicines go to the highest bidder. In Sick Money investigative journalist Billy Kenber offers a diagnosis of an industry in crisis and a prescription for how we can fight back.